Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Jae Park, M.D.
Hematologist Oncologist, Leukemia and Cell Therapy Center, Memorial Sloan Kettering Cancer Center
Richard Maziarz, M.D.
Medical Director, Blood and Marrow Transplant and Cellular Therapy, Oregon Health & Science University
Evren Alici, M.D., Ph.D.
Head of Cell and Gene Therapy, Karolinska Institute